Offer - Urjas Oil for just ₹ 1
Doxorubin 50 Injection is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Blood Cancer. Secondary and off-label uses of Doxorubin 50 Injection have also been mentioned below.
The right dosage of Doxorubin 50 Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Doxorubin 50 Injection include Hair Loss. Apart from the aforementioned side effects, Doxorubin 50 Injection can also lead to other problems, which have been listed below. These side effects of Doxorubin 50 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Doxorubin 50 Injection is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to Doxorubin 50 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Heart Failure must refrain from the use of Doxorubin 50 Injection since this can cause severe adverse effects. The section on Doxorubin 50 Injection contraindications lists all such conditions.
Besides this, Doxorubin 50 Injection may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Doxorubin 50 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Doxorubin 50 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Female) |
|
| Geriatric |
|
Is the use of Doxorubin 50 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Doxorubin. If you are pregnant, do not take Doxorubin without a doctor's advice.
Is the use of Doxorubin 50 Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Doxorubin. So it is adviced to consult the doctor before using it.
What is the effect of Doxorubin 50 Injection on the Kidneys?
Doxorubin is completely safe for kidneys.
What is the effect of Doxorubin 50 Injection on the Liver?
Doxorubin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Doxorubin 50 Injection on the Heart?
You may experience side effects on your heart after taking Doxorubin. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Doxorubin 50 Injection unless your doctor advises you to do so -
Is this Doxorubin 50 Injection habit forming or addictive?
No, you will not get addicted to Doxorubin 50 Injection.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Doxorubin 50 Injection. So it is best to avoid driving.
Is it safe?
Yes, but consume Doxorubin 50 Injection only on doctor's advice.
Is it able to treat mental disorders?
Doxorubin 50 Injection is unable to treat or cure mental disorders.
Interaction between Food and Doxorubin 50 Injection
It is safe to take Doxorubin 50 Injection with food.
Interaction between Alcohol and Doxorubin 50 Injection
Information about the interaction of Doxorubin 50 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 463-465
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Adriamycin (doxorubicin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Doxorubicin Hydrochloride (doxorubicin hydrochloride)
